Document ID: chunk:federal_register_of_legislation:F2023L01025:clause:2_4
Version: federal_register_of_legislation:F2023L01025
Segment Type: clause
Provision Reference: sch 2 cl 4
Character Range: 1803–3232

4  Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) health practitioner;
(b) medicine;
(c) product information;
(d) Register;
(e) registered goods;
(f) Secretary.
  In this instrument:
Act means the Therapeutic Goods Act 1989.
approved product information means the product information approved by the Secretary under section 25AA of the Act.
AusPAR means the Australian Public Assessment Report for a prescription medicine, including the attached approved product information, that is published by the TGA.
Note: AusPARs may also include the Clinical Evaluation Report, or an extract of the Clinical Evaluation Report, as an attachment. AusPARs are published on the TGA website at www.tga.gov.au.
Australian Prescriber means the journal published by Therapeutic Guidelines.
registered prescription medicine means a medicine that:
 (a) is included in the part of the Register for goods known as registered goods; and
 (b) would require a prescription from a health practitioner who is authorised to prescribe medicine under a law of a State or Territory.
Therapeutic Goods Administration, or TGA, means the part of the Department known as the Therapeutic Goods Administration.
therapeutic goods information has the meaning given by subsection 61(1) of the Act.
Therapeutic Guidelines means Therapeutic Guidelines Ltd (ABN 45 074 766 224).